Hinge Health (NYSE:HNGE) Coverage Initiated by Analysts at KeyCorp

KeyCorp began coverage on shares of Hinge Health (NYSE:HNGE) in a research note issued to investors on Monday morning, Marketbeat Ratings reports. The brokerage issued an overweight rating and a $45.00 target price on the stock.

Other equities analysts have also issued research reports about the company. Canaccord Genuity Group assumed coverage on Hinge Health in a research note on Monday. They issued a “buy” rating and a $52.00 target price on the stock. Barclays assumed coverage on Hinge Health in a research report on Monday. They set an “overweight” rating and a $43.00 price target on the stock. Finally, Wall Street Zen raised Hinge Health to a “hold” rating in a research report on Monday, June 2nd. One research analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company. Based on data from MarketBeat, Hinge Health presently has an average rating of “Moderate Buy” and an average target price of $46.00.

Hinge Health Stock Performance

NYSE:HNGE opened at $36.65 on Monday. Hinge Health has a 1-year low of $33.42 and a 1-year high of $43.80.

Hinge Health Company Profile

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.